Research area: Respiratory
Research Group: GReCMaR
Research Group in Chronic Respiratory Disease
Description
This research team is made up of professionals from different areas and levels of primary health care who carry out their work and research in various centres in the areas of north Barcelona and Maresme, under the guidance and with the participation of the North Metropolitan Research Support Unit. Some of the group's members form part of Maresme study group investigating Community-Acquired Pneumonia (GEMPAC). The basic objective of GReCMaR is to promote and consolidate knowledge within primary health care of the chronicity of respiratory diseases, knowledge which will lead to improved patient care and the optimum use of available resources. The group's lines are centered on prevention (giving up smoking, tertiary prevention, early detection and screening strategies), Service Evaluation (causes of COPD infradiagnosis and study of the diagnostic value of symptoms, signs and complementary tests) and the comobidity, longitudinality and treatment of patients with respiratory diseases.
Research Lines
Prevention and study of risk factors associated with COPD, Detection and infradiagnosis of COPD, Educational interventions in COPD, Lower respiratory tract infections, Tertiary prevention: study of the exacerbation of COPD.
Members
Projects
The group participates in the following projects:
PI: Ortega Hortas, Marcos. Sistema de análisis de microcirculación retiniana: evaluación multidisciplinar e integración en protocolos clínicos. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2017
PI: Casanova Uclés, Antonio. Anàlisi de situació i observatori de la medicina de família al Maresme. Funding: Fundació Acadèmia de les Ciencies Mèdiques. Duration: 2016 - 2017
PI: Caballería Rovira, Llorenç. Valor predictivo de la elastografía hepática transitoria respecto a la enfermedad hepática y cardiovascular. Funding: Instituto de Salud Carlos III. Duration: 2015 - 2017
PI: Reyes Lacalle, Azahara. Efectividad del asesoramiento anticonceptivo en el postparto. Estudio MAYA. Funding: Bayer Hispania, S.L. Duration: 2015 - 2017
PI: Moreno Hernandez, Isabel. Déficit de vitamina D como factor de riesgo de infección respiratoria (IRVB) y de agudización de la enfermedad pulmonar obstructiva crónica (EPOC). Funding: Fundació d´Atenció Primària (CAMFiC). Duration: 2015 - 2016
PI: Ramos Blanes, Rafel. Estudio epidemiológico de la Hipercolesterolemia Familiar. Estudio COLGE. Funding: IDIAP Jordi Gol. Duration: 2015 - 2016
PI: Morros Pedrós, Rosa. Uso de heparinas y nuevos anticoagulantes en atención primaria en Cataluña. Estudio Piloto. Funding: Bioiberica, S.A.U.. Duration: 2015 - 2016
PI: Alventosa Zaidin, Marina. Bloqueig de branca i morbimortalitat cardiovascular. Funding: Fundació Acadèmia de les Ciencies Mèdiques. Duration: 2015 - 2016
PI: Simonet Aineto, Pere Josep. Factores predictivos de ingreso hospitalario en las exacerbaciones de EPOC tratadas inicialmente en Atención Primaria. Funding: ICS - Institut Català de la Salut. Duration: 2014 - 2016
PI: Mataró Serrat, Maria. Neuroplasticidad en la edad adulta: Ejercicio físico y entrenamiento cognitivo. Funding: Ministerio de Economía y Competitividad. Duration: 2014 - 2016
PI: Montero Alía, Pilar. Efectividad de una intervención realizada en atención primaria de la consola Wii de Nintendo para mejorar el equilibrio y disminuir las caídas en personas mayores. Funding: Instituto de Salud Carlos III. Duration: 2013 - 2016
PI: de la Poza Abad, Mariam. Ensayo clínico sobre la evaluación de la prescripción diferida de antibióticos en las infecciones respiratorias agudas no complicadas en pediatría (PDA-pediatría). Funding: Instituto de Salud Carlos III. Duration: 2012 - 2016
Publications
The group participates in the following publications:
Monteagudo M, Rodríguez-Blanco T, Barrecheguren M, Simonet P, Miravitlles M. Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study Respir Med. 2016;121:26-31. PMID:27888988. FI: 3,036.
Alzamora MT, Forés R, Pera G, Baena-Díez JM, Heras A, Sorribes M, Valverde M, Muñoz L, Mundet X, Torán P. Incidence of peripheral arterial disease in the ARTPER population cohort after 5 years of follow-up. BMC cardiovascular disorders. 2016 ; 16:8. doi:10.1186/s12872-015-0170-6. Epub 2016 Jan 12. pmc:PMC4710015. PMID:26758025. FI: 2,021.
Arbillaga-Etxarri A, Torrent-Pallicer J, Gimeno-Santos E, Barberan-Garcia A, Delgado A, Balcells E, Rodríguez DA, Vilaró J, Vall-Casas P, Irurtia A, Rodriguez-Roisin R, Garcia-Aymerich J; Urban Training? Study Group. Validation of Walking Trails for the Urban Training? of Chronic Obstructive Pulmonary Disease Patients. PLoS One. 2016 Jan 14;11(1):e0146705 FI: 3,057.
Barrecheguren M, Monteagudo M, Ferrer J, Borrell E, Llor C, Esquinas C, Miravitlles M. Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study. Respiratory medicine. 2016 Feb; 111:47-53. doi:10.1016/j.rmed.2015.12.004. Epub 2015 Dec 23. PMID:26758585. FI: 3,036.
Barrecheguren M, Monteagudo M, Simonet P, Llor C, Rodriguez E, Ferrer J, Esquinas C, Miravitlles M. Diagnosis of alpha-1 antitrypsin deficiency: a population-based study. Int J Chron Obstruct Pulmon Dis. 2016 May 10;11:999-1004. doi: 10.2147/COPD.S108505. PubMed PMID: 27274221; PubMed Central PMCID:PMC4869627.
Caballería L, Pera G, Rodríguez L, Casas JD, Miranda D, Auladell MA, Buezo I, Expósito C, Arteaga I, Torán P. Acceptability and quality of abdominal ultrasound studies requested by medical professionals. Gastroenterologia y hepatologia. 2016 Oct; 39(8):516-25. doi:10.1016/j.gastrohep.2016.01.014. Epub 2016 Mar 19. Spanish. PMID:27006137. FI: 0,640.
de la Poza Abad M, Mas Dalmau G, Moreno Bakedano M, González González AI, Canellas Criado Y, Hernández Anadón S, Rotaeche del Campo R, Torán Monserrat P, Negrete Palma A, Muñoz Ortiz L, Borrell Thió E, Llor C, Little P, Alonso-Coello P; Delayed Antibiotic Prescription (DAP) Group. Prescription Strategies in Acute Uncomplicated Respiratory Infections: A Randomized Clinical Trial. JAMA internal medicine. 2016 Jan; 176(1):21-9. doi:10.1001/jamainternmed.2015.7088. PMID:26719947. FI: 14,000.
de la Torre MC, Torán P, Serra-Prat M, Palomera E, Güell E, Vendrell E, Yébenes JC, Torres A, Almirall J. Serum levels of immunoglobulins and severity of community-acquired pneumonia. BMJ open respiratory research. 2016 ; 3(1):e000152. doi:10.1136/bmjresp-2016-000152. Epub 2016 Nov 28. pmc:PMC5133423. PMID:27933180.
Fernández-Cano MI, Espada-Trespalacios X, Reyes-Lacalle A, Manresa Domínguez JM, Armadans-Gil L, Campins-Martí M, Falguera-Puig G, Toran Monserrat P. [Vaccination coverage against pertussis in pregnant women of Catalonia in the first year of implementation of the immunisation program]. Enfermedades infecciosas y microbiologia clinica. 2016 Oct; doi:10.1016/j.eimc.2016.09.008. Epub 2016 Oct 18. Spanish. PMID:27769682. FI: 1,530.
Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AKMontero P, Negrete A, Torán P. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists. Br J Haematol. Br J Anaesth. 2016;4:610-623. PMID:27071942. FI: 5,616.
Guiriguet C, Muñoz-Ortiz L, Burón A, Rivero I, Grau J, Vela-Vallespín C, Vilarrubí M, Torres M, Hernández C, Méndez-Boo L, Toràn P, Caballeria L, Macià F, Castells A. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care. The British journal of general practice : the journal of the Royal College of General Practitioners. 2016 Jul; 66(648):e483-90. doi:10.3399/bjgp16X685657. Epub 2016 Zer 06. pmc:PMC4917051. PMID:27266861. FI: 2,741.
Montero-Alía P, Muñoz-Ortiz L, Jiménez-González M, Benedicto-Pañell C, Altimir-Losada S, López-Colomer Y, Prat-Rovira J, Amargant-Rubio JF, Jastes SM, Moreno-Buitrago A, Rodríguez-Pérez MC, Teixidó-Vargas C, Albarrán-Sánchez JL, Candel-Gil A, Serra-Serra D, Martí-Cervantes JJ, Sánchez-Pérez CA, Sañudo-Blanco L, Dolader-Olivé S, Torán-Monserrat P. Study protocol of a randomized clinical trial evaluating the effectiveness of a primary care intervention using the Nintendo? Wii console to improve balance and decrease falls in the elderly. BMC geriatrics. 2016 ; 16:8. doi:10.1186/s12877-015-0178-x. Epub 2016 Jan 12. pmc:PMC4722618. PMID:26796956.
Muñoz-Miralles R, Ortega-González R, López-Morón MR, Batalla-Martínez C, Manresa JM, Montellà-Jordana N, Chamarro A, Carbonell X, Torán-Monserrat P. The problematic use of Information and Communication Technologies (ICT) in adolescents by the cross sectional JOITIC study. BMC pediatrics. 2016 ; 16(1):140. doi:10.1186/s12887-016-0674-y. Epub 2016 Aug 22. pmc:PMC4994264. PMID:27550020.
Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ; AUSTRI Investigators. Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone. N Engl J Med. 2016 May 12;374(19):1822-30. doi: 10.1056/NEJMoa1511049. Epub 2016 Mar 6. PubMed PMID: 26949137. FI: 59,558.
Vázquez Dorrego XM, Manresa Domínguez JM, Heras Tebar A, Forés R, Girona Marcé A, Alzamora Sas MT, Delgado Martínez P, Riba-Llena I, Ugarte Anduaga J, Beristain Iraola A, Barandiaran Martirena I, Ruiz Bilbao SM, Torán Monserrat P. Semi-automatic measuring of arteriovenous relation as a possible silent brain infarction risk index in hypertensive patients. Archivos de la Sociedad Espanola de Oftalmologia. 2016 Nov; 91(11):513-519. doi:10.1016/j.oftal.2016.05.001. Epub 2016 Jun 13. PMID:27311989..
Awards:
Best poster. Institut de Neurociències de la Universitat de Barcelona. Influence of physical activity and genetics on cognition. Alzamora MT, Pera G, Torán P.
Best project. Sociedad española de farmaceuticos de atención primaria. Prescripción de psicofármacos en pacientes con demència. Massot M, Tristany M, Torán P, Franzi A, Hernández O.
Indicators
Indicator | 2016 |
---|---|
Researchers with PhD | 2 |
Total number of projects in which group members have participated | 12 |
Total number of projects in which the PI of the project has belonged to the group | 1 |
Total Funding | 380.038,45€ |
Scientific publications in indexed journals | 9 |
Total Impact factor | 95,24 |
Nº of articles in Q1 journals | 5 |
Q1 FI | 84,972 |
Nº of articles in Q2 journals | 2 |
Q2 FI | 6,072 |